Genomics Market 2021 Research and Clinical Analysis -10X Genomics, Qiagen NV, Fluidigm Corporation, Johnson & Johnson Private Limited

The Global Genomics Market Research Report 2021-2030 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope, and application of this report.

The global genomics market was worth $851.96 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 14.71% and reach $1475.11 million by 2023.

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/05072013882/genomics-market-global-report-2020-30-including-1-by-product-type-instrument-including-systems-service-contract-and-software-reagents-including-reagents-and-consumables-2-by-process-cell-isolation-sample-preparation-genomic-analysis-3-by-end-user-academic-institutes-biopharmaceutical-companies-clinical-research-institutes-covering-10x-genomics-qiagen-nv-fluidigm-corporation-johnson-johnson-private-limited-zephyrus-biosciences-inc/inquiry?Mode=74    

Key Market Players:

10X Genomics, Qiagen NV, Fluidigm Corporation, Johnson & Johnson Private Limited, Zephyrus Biosciences Inc., Illumina, Inc., Affymetrix, Angle PLC, Denovo Sciences Inc. and Diagnologix LLC. and Other

Rising government funds for research on genomics drives the growth of the single-cell genomics market. The government funding focuses on efforts to resolve the complexity of the human genome, define the genomic basis of human health and disease, and ensure that genomics is used safely to enhance patient care and benefit society through government, public and private institutions. For instance, in 2018, in the U.S, The All of Us Research Program, a part of the National Institutes of Health, gave funds of $28.6 million for establishing three genome centers in the USA. These centers will start generating genomic data from the biosamples contributed by the participants of the program.

The technology limitation in single-cell genomics hinders the growth of the single-cell genomics market. Due to cost and technical constraints, the use of genetic sequencing to better target and treat rare and chronic diseases was largely out of reach for most health care organizations. Therefore, limiting the markets growth.

Companies are investing in new product launches to increase their revenue and expand their consumer base and also for gaining a competitive edge over their rivals. For instance, in 2018, NanoString Technologies, Inc., a USA-based biotech company, specialized in developing cancer diagnostics tools launched a CAR-T characterization panel, a new gene expression panel for the molecular characterization of CAR-T cells in research, development, and manufacturing. The panel was developed in partnership with eight leading CAR-T therapy centers and helps in ease of workflow and aims to advance the field of CAR-T therapy.

In November 2019, Exact Sciences Corp., a USA-based molecular diagnostics company specialized in colon cancer screening, screening test research, and development, non-invasive cancer screening for early detection and prevention of colorectal cancer, acquired Genomic Health Inc. for $2.8 billion in cash. The acquisition is expected to help Exact Sciences Corp. to broaden its offering of cancer tests and expand its footprint in more than 90 countries. Genomic Health Inc. is a USA-based life science company that specializes in the development of genomic-based clinical diagnostic tests for cancer.

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/05072013882/genomics-market-global-report-2020-30-including-1-by-product-type-instrument-including-systems-service-contract-and-software-reagents-including-reagents-and-consumables-2-by-process-cell-isolation-sample-preparation-genomic-analysis-3-by-end-user-academic-institutes-biopharmaceutical-companies-clinical-research-institutes-covering-10x-genomics-qiagen-nv-fluidigm-corporation-johnson-johnson-private-limited-zephyrus-biosciences-inc?Mode=74   

The market factors explained in the report:

Market Overview: It includes Genomics Market study scope, top key players, segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: The Genomics Market report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Regional Study: All of the regions and countries analyzed in the Genomics Market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Key Players: This part of the Genomics Market report discusses expansion plans of companies, key mergers and acquisitions, funding and investment analysis, company establishment dates, revenues of manufacturers, and their areas served and manufacturing bases.

Market Forecast: Here, the report offers a complete forecast of the global Genomics Market by product, application, and region. It also offers global sales and revenue forecasts for all years of the forecast period.

The research includes historic data from 2015 to 2021 and forecasts until 2030 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Note: All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply-chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.